Thomas Charles Heineman - 12 Feb 2026 Form 4 Insider Report for ONCOLYTICS BIOTECH INC (ONCY)

Role
Chief Medical Officer
Signature
/s/ Kirk Look, Attorney-in-Fact
Issuer symbol
ONCY
Transactions as of
12 Feb 2026
Net transactions value
+$10,033
Form type
4
Filing time
13 Feb 2026, 07:00:28 UTC
Previous filing
02 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Heineman Thomas Charles Chief Medical Officer C/O ONCOLYTICS BIOTECH INC., 4350 EXECUTIVE DRIVE, SUITE 325, SAN DIEGO /s/ Kirk Look, Attorney-in-Fact 13 Feb 2026 0002103579

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONCY Common Shares Purchase $10,033 +12,132 +4.5% $0.8270 282,818 12 Feb 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.